Sector Influencing 7.3% CAGR for Hereditary Angioedema Market (2021-2027)

The global Hereditary Angioedema market was valued at US$ 1656.7 million in 2020 and is expected to reach US$ 2724.1 million by the end of 2027, growing at a CAGR of 7.3% during 2021-2027.

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

Global Hereditary Angioedema Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Hereditary Angioedema Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.

Key Companies profiled in this report are Pharming Group NV, Takeda, CSL Limited, iBio Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc. and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.

Find more details at:

Segment by Type

  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Selective Bradykinin B2 Receptor Antagonist

Segment by Application

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Table of Content:

1 Hereditary Angioedema Market Overview

2 Hereditary Angioedema Market Competition by Manufacturers

3 Hereditary Angioedema Retrospective Market Scenario by Region

4 Global Hereditary Angioedema Historic Market Analysis by Type

5 Global Hereditary Angioedema Historic Market Analysis by Application

6 Key Companies Profiled

7 Hereditary Angioedema Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Hereditary Angioedema Market Dynamics

10 Global Hereditary Angioedema Market Forecast

11 Research Finding and Conclusion

12 Methodology and Data Source

Media Contact

Company Name: The Market Reports

Contact Person: Shirish Gupta


Phone: +1-631-407-1315